← ANALYSTS · TIPRANKS
Kate Dellorusso · LifeSci Capital
Hits
57%
8 of 14 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+7.2%
Over a year after the rating, TipRanks’ measure
Our companies rated now
2
Buy / hold / sell: 2 / 0 / 0
Upside of the analyst’s targets
+442.4%
Average over 2 current targets, to the last price
The market’s answer to the ratings
—
No upgrade, downgrade or target change with a known move yet
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 1on TipRanks 17:15 | ACRSIWMAclaris Therapeutics · $514M | Reiterated | Buy | $13.00 | +296.3% | −1.2%next day −3.4% · 5 days −13.9% | ↗ |
| Sep 1on TipRanks 18:25 | UPBIWMUpstream Bio, Inc. · $185M | Reiterated | Buy | $19.00 | +588.4% | −1.5%next day −7.2% · 5 days −10.3% | ↗ |
| Aug 6on TipRanks 16:39 | ACRSIWMAclaris Therapeutics · $514M | Reiterated | Buy | $13.00 | +296.3% | −3.6%next day −0.1% · 5 days −2.6% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗